Prestige Consumer Healthcare
PBH
#4654
Rank
A$3.26 B
Marketcap
A$69.02
Share price
0.75%
Change (1 day)
-26.74%
Change (1 year)

EPS for Prestige Consumer Healthcare (PBH)

EPS in 2026 (TTM): A$5.29

According to Prestige Consumer Healthcare's latest financial reports the company's current EPS (TTM) is A$5.14. In 2025 the company made an earnings per share (EPS) of A$5.45 a decrease over its 2024 EPS that were of A$6.15.

EPS history for Prestige Consumer Healthcare from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A$5.29-2.91%
2025A$5.45-11.4%
2024A$6.15-367.08%
2023A-$2.30-138.33%
2022A$6.0111.7%
2021A$5.3813.6%
2020A$4.74-651.67%
2019A-$0.86-148.78%
2018A$1.76-83.29%
2017A$10.53437.23%
2016A$1.96-34.13%
2015A$2.9852.94%
2014A$1.95-8.11%
2013A$2.12
2011A$1.25

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
A$12.50 143.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Procter & Gamble
PG
A$9.67 88.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$9.53 85.52%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$1.09-78.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
A$4.46-13.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Clorox
CLX
A$8.84 72.14%๐Ÿ‡บ๐Ÿ‡ธ USA
CVS Health
CVS
A$3.31-35.65%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$4.58-10.93%๐Ÿ‡ฌ๐Ÿ‡ง UK
Rite Aid
RAD
A-$42.39-925.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Taro Pharmaceutical
TARO
A$1.75-66.02%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel